{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:35:16Z","timestamp":1767065716668},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China under the Young Scientists Fund Program.","award":["No. 81803918"],"award-info":[{"award-number":["No. 81803918"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atypical chronic myeloid leukemia (aCML) is a highly aggressive type of blood cancer that falls under the category of myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN). In the fifth edition of the WHO classification of tumors, this category has been renamed MDS\/MPN with neutrophilia. Although eosinophilia is commonly observed in blood cancers, it is rarely seen in aCML.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This study presents a case of aCML that was diagnosed six years after the patient developed eosinophilia. The patient had undergone tests to rule out other primary and secondary diseases, but the eosinophilia remained unexplained. Treatment with corticosteroids and hydroxyurea had proven ineffective. Six years later, the patient experienced an increase in white blood cells, primarily neutrophils. After ruling out other possible diagnoses, a combination of morphologic and molecular genetic findings led to the diagnosis of aCML. The patient responded well to treatment with azacitidine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study summarizes the current state of aCML diagnosis and management and discusses the possible connection between eosinophilia and aCML.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-024-05196-7","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:02:28Z","timestamp":1720699348000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atypical chronic myeloid leukemia found in a patient with eosinophilia for six years: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Moqin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"issue":"11","key":"5196_CR1","first-page":"1566","volume":"91","author":"M Breccia","year":"2006","unstructured":"Breccia M, Biondo F, Latagliata R, Carmosino I, Mandelli F, Alimena G. Identification of risk factors in atypical chronic myeloid leukemia. Haematologica. 2006;91(11):1566\u20138.","journal-title":"Haematologica"},{"issue":"20","key":"5196_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","journal-title":"Blood"},{"issue":"7","key":"5196_CR3","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and Histiocytic\/Dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319. https:\/\/doi.org\/10.1038\/s41375-022-01613-1.","journal-title":"Leukemia"},{"issue":"4","key":"5196_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ajh.26828","volume":"98","author":"MM Patnaik","year":"2023","unstructured":"Patnaik MM, Tefferi A. Atypical chronic myeloid leukemia and myelodysplastic\/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023;98(4):681\u20139. https:\/\/doi.org\/10.1002\/ajh.26828.","journal-title":"Am J Hematol"},{"issue":"10","key":"5196_CR5","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","volume":"83","author":"PF Weller","year":"1994","unstructured":"Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83(10):2759\u201379.","journal-title":"Blood"},{"issue":"2","key":"5196_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/ehm.11.81","volume":"5","author":"P Valent","year":"2012","unstructured":"Valent P, Gleich GJ, Reiter A, et al. Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol. 2012;5(2):157\u201376. https:\/\/doi.org\/10.1586\/ehm.11.81.","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"5196_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajh.26352","volume":"97","author":"W Shomali","year":"2022","unstructured":"Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(1):129\u201348. https:\/\/doi.org\/10.1002\/ajh.26352.","journal-title":"Am J Hematol"},{"issue":"17","key":"5196_CR8","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/blood-2014-02-553800","volume":"123","author":"SA Wang","year":"2014","unstructured":"Wang SA, Hasserjian RP, Fox PS, et al. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic\/myeloproliferative neoplasms. Blood. 2014;123(17):2645\u201351. https:\/\/doi.org\/10.1182\/blood-2014-02-553800.","journal-title":"Blood"},{"issue":"9","key":"5196_CR9","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1182\/bloodadvances.2022008204","volume":"7","author":"G Carre\u00f1o-Tarragona","year":"2023","unstructured":"Carre\u00f1o-Tarragona G, \u00c1lvarez-Larr\u00e1n A, Harrison C, et al. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes. Blood Adv. 2023;7(9):1672\u201381. https:\/\/doi.org\/10.1182\/bloodadvances.2022008204.","journal-title":"Blood Adv"},{"key":"5196_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-014-0093-1","volume":"7","author":"B Li","year":"2014","unstructured":"Li B, Gale RP, Xiao Z. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia. J Hematol Oncol. 2014;7:93. https:\/\/doi.org\/10.1186\/s13045-014-0093-1. Published 2014 Dec 12.","journal-title":"J Hematol Oncol"},{"issue":"16","key":"5196_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1182\/blood.2019004229","volume":"136","author":"L Palomo","year":"2020","unstructured":"Palomo L, Meggendorfer M, Hutter S, et al. Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms. Blood. 2020;136(16):1851\u201362. https:\/\/doi.org\/10.1182\/blood.2019004229.","journal-title":"Blood"},{"issue":"8","key":"5196_CR12","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1038\/s41375-021-01121-8","volume":"35","author":"X Fang","year":"2021","unstructured":"Fang X, Xu S, Zhang Y, et al. Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish. Leukemia. 2021;35(8):2299\u2013310. https:\/\/doi.org\/10.1038\/s41375-021-01121-8.","journal-title":"Leukemia"},{"issue":"1","key":"5196_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","volume":"45","author":"R Piazza","year":"2013","unstructured":"Piazza R, Valletta S, Winkelmann N, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet. 2013;45(1):18\u201324. https:\/\/doi.org\/10.1038\/ng.2495.","journal-title":"Nat Genet"},{"issue":"2","key":"5196_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/MOH.0000000000000565","volume":"27","author":"S Sadigh","year":"2020","unstructured":"Sadigh S, Hasserjian RP, Hobbs G. Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms. Curr Opin Hematol. 2020;27(2):122\u20137. https:\/\/doi.org\/10.1097\/MOH.0000000000000565.","journal-title":"Curr Opin Hematol"},{"issue":"19","key":"5196_CR15","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","volume":"368","author":"JE Maxson","year":"2013","unstructured":"Maxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368(19):1781\u201390. https:\/\/doi.org\/10.1056\/NEJMoa1214514.","journal-title":"N Engl J Med"},{"issue":"7","key":"5196_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1182\/blood-2016-08-693630","volume":"129","author":"J Gotlib","year":"2017","unstructured":"Gotlib J. How I treat atypical chronic myeloid leukemia. Blood. 2017;129(7):838\u201345. https:\/\/doi.org\/10.1182\/blood-2016-08-693630.","journal-title":"Blood"},{"issue":"2","key":"5196_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.hoc.2020.12.005","volume":"35","author":"AT Kuykendall","year":"2021","unstructured":"Kuykendall AT, Tokumori FC, Komrokji RS. Traipsing through Muddy Waters: a critical review of the myelodysplastic Syndrome\/Myeloproliferative neoplasm (MDS\/MPN) overlap syndromes. Hematol Oncol Clin North Am. 2021;35(2):337\u201352. https:\/\/doi.org\/10.1016\/j.hoc.2020.12.005.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Supplement 1","key":"5196_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1182\/blood-2023-182879","volume":"142","author":"AT Kuykendall","year":"2023","unstructured":"Kuykendall AT, Pettit KM, Singh A, et al. A phase 2 study of Fedratinib in patients with MDS\/MPN and chronic neutrophilic leukemia. Blood. 2023;142(Supplement 1):73\u201373. https:\/\/doi.org\/10.1182\/blood-2023-182879.","journal-title":"Blood"},{"issue":"1","key":"5196_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-018-0774-4","volume":"17","author":"S Rocca","year":"2018","unstructured":"Rocca S, Carr\u00e0 G, Poggio P, Morotti A, Brancaccio M. Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia. Mol Cancer. 2018;17(1):40. https:\/\/doi.org\/10.1186\/s12943-018-0774-4. Published 2018 Feb 19.","journal-title":"Mol Cancer"},{"issue":"6","key":"5196_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ajh.24722","volume":"92","author":"MM Patnaik","year":"2017","unstructured":"Patnaik MM, Barraco D, Lasho TL, et al. Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. Am J Hematol. 2017;92(6):542\u20138. https:\/\/doi.org\/10.1002\/ajh.24722.","journal-title":"Am J Hematol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05196-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05196-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05196-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:03:46Z","timestamp":1720699426000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05196-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5196"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05196-7","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"assertion":[{"value":"30 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the patient\u2019s clinical details and\/or clinical images was obtained from the relative of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"595"}}